The Influence of Antidepressants on the Immune System

Abstract

Depression is one of the most frequently diagnosed condition in psychiatry. Despite the availability of many preparations, over 30% of treated patients do not achieve remission. Recently the emphasis is put on the contribution of the body’s inflammatory response as one of the causes of depression. The interactions between nervous and immune systems are the main issue addressed by psychoneuroimmunology. In patients suffering from depression changes in the plasma concentrations of cytokines and in the number and level of activation of immune cells has been found. Attention is paid to the high levels of pro-inflammatory cytokines, the prevalence of Th1 responses to Th2, weakening of NK cell cytotoxicity and changes in lymphocyte proliferation and apoptosis. A number of studies focus on influence of antidepressants and non-standard methods of depression treatment, such as ketamine infusion, on patients’ immunology. Many of them seem to regulate the immune responses. The study results encourage to look for new ways to treat depression with immunomodulatory drugs. In this article authors present the current knowledge about immune system changes accompanying depression as well as the study results showing the influence of drugs on the immune system, especially in the context of reducing the symptoms of depression.

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

“…Antidepressants have been consistently shown to have anti-inflammatory proprieties, although little is known about their possible role in systemic infections [ 38 , 54 , 84 ]. In vitro studies showed a protective effect against bacteria and fungi [ 26 ], but clinical data are unclear, as a possibly higher risk of Clostridium difficile infection has been reported [ 47 ].…”

Curcumin: Could This Compound Be Useful in Pregnancy and Pregnancy-Related Complications?

“…Curcumin can influence the unbalanced release of monoamine neurotransmitters—such as serotonin (5-HT), dopamine (DA), noradrenaline, and glutamate—the expression of monoamine oxidase (MAO), the expression of neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and neurogenesis, as well as the dysregulated immune system function and oxidative and nitrosative stress. Thus, curcumin appears to promote neurogenesis and inhibit neuronal cell apoptosis [ 83 , 84 , 92 , 93 ]. Despite the consistent evidence of efficacy and safety of curcumin treatment in other pathological conditions, to date, data on its effects on depression in pregnancy are completely lacking.…”

<p>The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19)</p>

“…In the interim guidance document of WHO, when the novel coronavirus was suspected, it was mentioned that utilizing vasopressors (norepinephrine, epinephrine, and dopamine most safely received from a central venous catheter) helps clinicians in managing the patients with acute respiratory failure and septic shock, as a consequence of severe infection. 57,85,86 Based on the described role of host immune responses, in overcoming the infection disease, it has been recommended that serotonergic and dopaminergic pathways are attractive targets to treat the human infectious disease. For example, fluoxetine, by its action on the serotonergic pathway in the central nervous system, regulates the neuroendocrine signals and also modulates the immune response against infection.…”